Strata Critical Medical, Inc. (SRTA) P/E Ratio History
Deep ValueTrading at 10.6x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2020–2020
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, Strata Critical Medical, Inc. (SRTA) trades at a price-to-earnings ratio of 10.6x, with a stock price of $5.30 and trailing twelve-month earnings per share of $0.52.
The current P/E is 93% below its 5-year average of 147.4x. Over the past five years, SRTA's P/E has ranged from a low of 118.3x to a high of 176.6x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Industrials sector median P/E of 26.6x, SRTA trades at a 60% discount to its sector peers. The sector includes 400 companies with P/E ratios ranging from 0.1x to 198.6x.
Relative to the broader market, SRTA trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SRTA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SRTA Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
SRTA P/E vs Peers
Air cargo and express logistics peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $10B | 27.9 | 2.02 | +14% | |
| $2B | 18.6Lowest | 0.92Best | +23% | |
| $2B | 30.0 | - | +53%Best | |
| $388B | 32.3 | - | -15% | |
| $46B | 39.0 | - | -1% | |
| $133B | 75.1 | - | -62% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
SRTA Historical P/E Data (2020–2020)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2020 Q3 | Sep 30 2020 | $10.05 | $0.06 | 176.6x | +20% |
| FY2020 Q2 | - | $9.97 | $0.08 | 118.3x | -20% |
Average P/E for displayed period: 147.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SRTA — Frequently Asked Questions
Quick answers to the most common questions about buying SRTA stock.
What is SRTA's P/E ratio?
Strata Critical Medical, Inc. (SRTA) trailing twelve-month P/E ratio is 10.6x, based on TTM diluted EPS of $0.52. The 5-year average P/E is 147.4x and the historical range spans 118.3x to 176.6x.
Is SRTA stock overvalued or undervalued?
SRTA trades at 10.6x P/E, below its 5-year average of 147.4x. At the 0th percentile of its historical range (118.3x–176.6x), the stock is priced at a discount to its own history.
Is SRTA stock expensive?
No, SRTA is not expensive on a historical basis. The current P/E of 10.6x is below the 5-year average of 147.4x and sits at the 0th percentile of its valuation range.
What is SRTA's historical P/E range?
Over the past 5 years, SRTA's P/E ratio has ranged from 118.3x to 176.6x, with a median of 176.6x and an average of 147.4x. The current P/E of 10.6x places the stock at the 0th percentile of this range. Full historical data spans 2020–2020.
How does SRTA's P/E compare to the S&P 500?
SRTA trades at 10.6x P/E versus the S&P 500 median of 25.3x. The 58% discount to the market suggests lower growth expectations or perceived higher risk.
How does SRTA's valuation compare to Industrials peers?
Strata Critical Medical, Inc. P/E of 10.6x compares to the Industrials sector median of 26.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is SRTA's PEG ratio?
SRTA PEG ratio is N/A, based on a P/E of 10.6x and EPS growth of 242.9%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is SRTA's earnings yield?
SRTA earnings yield is 9.43%, the inverse of its 10.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.